Generic Drug Pricing Transparency Could Reduce Spending, Study Says
Executive Summary
Every $1 reduction in the average reimbursement for a generic prescription would reduce US healthcare spending by $4bn, according to a study from Brookings, which concludes more generic drug pricing information should be selectively available to third-party payers.